Literature DB >> 1862156

Clinical studies on growth factors in pressure sores: preliminary report.

M C Robson1, L G Phillips, J P Heggers, M A McPherson, L S Heiner.   

Abstract

Agents touted to benefit chronic non-healing wounds will become evermore prevalent. Examples, in addition to those cited, might include epictor (EGF) or platelet derived growth factor (PDGF). Although they may look promising in in vitro and experimental animal studies, they must be tested in humans. The pressure sore is a chronic three dimensional wound which lends itself to study of wound healing agents. It has been used for severe such trials and appears to be an excellent model for the continued study of peptide growth factors.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1862156

Source DB:  PubMed          Journal:  Prog Clin Biol Res        ISSN: 0361-7742


  1 in total

1.  Human pilot studies reveal the potential of a vitronectin: growth factor complex as a treatment for chronic wounds.

Authors:  Zee Upton; Hilary J Wallace; Gary K Shooter; Derek R van Lonkhuyzen; Sim Yeoh-Ellerton; Erin A Rayment; Jacqui M Fleming; Daniel Broszczak; Douglas Queen; R Gary Sibbald; David I Leavesley; Michael C Stacey
Journal:  Int Wound J       Date:  2011-10       Impact factor: 3.315

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.